'Lv mass' diaporamas de présentation

EVALUATION OF SYSTOLIC FUNCTION OF LEFT VENTRICLE BY ECHOCARDIOGRAPHY

EVALUATION OF SYSTOLIC FUNCTION OF LEFT VENTRICLE BY ECHOCARDIOGRAPHY. DR SANDEEP.R SR CARDIO. Basic Principle. Systole The period of the cardiac cycle from the closure of the mitral valve to the closure of the aortic valve. EJECTION FRACTION.

3.51k views • 109 slides

EVALUATION OF SYSTOLIC FUNCTION

934 views • 68 slides

EVALUATION OF SYSTOLIC FUNCTION

952 views • 68 slides

The Heart in Hypertension

The Heart in Hypertension. Jamil Mayet. Left Ventricular Hypertrophy - a historical perspective. Association between renal disease and LVH Richard Bright 1836 Hypertrophy of large and small vessels related to LVH in kidney disease George Johnson 1852

504 views • 36 slides

Hypertensive Heart Disease

Hypertensive Heart Disease. Gene Bukhman January 12 th , 2005. Epidemiology I. Number of Patients with Hypertension in the United States: 50 million Number of Patients with Heart Failure: 5 million Percent of Heart Failure Patients with Hypertension: 75%. JNC 7. 2004

627 views • 27 slides

Intracoronary Autologous Bone-Marrow Cell Transfer after Myocardial Infarction: A Double-Blind, Randomized, and Placebo-

Intracoronary Autologous Bone-Marrow Cell Transfer after Myocardial Infarction. Intracoronary Autologous Bone-Marrow Cell Transfer after Myocardial Infarction: A Double-Blind, Randomized, and Placebo-Controlled Clinical Trial. Presented at American College of Cardiology

223 views • 6 slides

Effect of Spironolactone on LV Hypertrophy in Chronic Renal Disease

Effect of Spironolactone on LV Hypertrophy in Chronic Renal Disease. LV: -14 g with spironolactone vs. 3 g with placebo (p < 0.01) PW velocity: -0.8 m/s vs. -0.1 m/s (p < 0.01) Systolic blood pressure: -11 mm Hg vs. -5 mm Hg (p < 0.05).

150 views • 1 slides

Area at risk

Infarct size. **. *. 31.4%. 27.7%. 17.1%. Infarct size (% of LV-mass). n=7. n=5. n=7. Pre-reperfusion hypothermia. Post-reperfusion hypothermia. Normothermia. B. A. Area at risk. Infarct size / Area at risk. *. *. 42.0%. 80.4%. 38.9%. 74.8%. 34.9%. 45.9%.

80 views • 1 slides